Loading…
Reported covered position: Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
Issues related to renewable natural gas.
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Source: Senate LDA
| AVIDITY BIOSCIENCES, INC. |
| 10 |
| 2024–2026 |
| NCTA-THE INTERNET & TELEVISION ASSOCIATION | 10 | 2024–2026 |
| DECISION SCIENCES INTERNATIONAL CORP | 9 | 2024–2026 |
| TELEVISAUNIVISION, INC. | 9 | 2024–2026 |
| Fresenius Kabi USA, LLC | 8 | 2025–2026 |
| GLOBAL GRAB TECHNOLOGIES | 8 | 2025–2026 |
| CURALEAF, INC. | 7 | 2025–2026 |
| RARE DISEASE COMPANY COALITION | 7 | 2025–2026 |
| ALLIANCE FOR AUTOMOTIVE INNOVATION | 6 | 2025–2026 |
| STOKE THERAPEUTICS | 6 | 2025–2026 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) | 5 | 2025–2026 |
| APTIV | 4 | 2026 |
| ASSOCIATION FOR ACCESSIBLE MEDICINES | 4 | 2026 |
| ATRIUM THERAPEUTICS | 4 | 2026 |
| RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) | 4 | 2025–2026 |
| SURGENEX | 4 | 2025–2026 |
| SOUTH COAST AIR QUALITY MANAGEMENT DISTRICT | 3 | 2025 |
| GOGO BUSINESS AVIATION LLC | 2 | 2026 |
| NEURELIS, INC. | 2 | 2026 |
| THE ERISA INDUSTRY COMMITTEE (ERIC) | 2 | 2026 |
| ZEBRA TECHNOLOGIES CORPORATION | 2 | 2024–2025 |
| AGE IN PLACE | 1 | 2026 |
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
National Defense Authorization Act for Fiscal Year 2026
Client: VIATRIS INC · Firm: FEROX STRATEGIES
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC. · Firm: FEROX STRATEGIES
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS).
Equitable Community Access to Pharmacist Services Act
Client: WALMART INC. · Firm: FEROX STRATEGIES
Discussions regarding H.R.1770/S.2477, Equitable Community Access to Pharmacist Services Act (ECAPS).
Issues related to general tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
Discussions regarding Medicare coverage for pharmacy services.
General issues related to organized retail crime and pricing.
General issues related to trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via FEROX STRATEGIES
2026 · third_quarter · Q3
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2026 · third_quarter · Q3
General issues related to skin substitutes.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
STOKE THERAPEUTICS via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to rare disease treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to rare disease treatment development.
General issues related to rare disease treatment.
General issues related to tariffs.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to the tobacco industry.
Issues related to illicit trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEURELIS, INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to epilepsy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NCTA-THE INTERNET & TELEVISION ASSOCIATION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to telecommunications, spectrum, and rural broadband. General issues related to privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RETAIL FEDERATION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to organized retail crime.
General issues related to trade.
General Issues related to technology and artificial intelligence.
NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to radiopharmaceuticals.
General issues related to radiopharmaceutical tariffs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
GOGO BUSINESS AVIATION LLC via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to aviation.
General issues related to inflight communications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL GRAB TECHNOLOGIES via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to the deployment of technology at ports of entry.
General issues related to Homeland Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to trade.
General healthcare issues related to biosimilar industries.
General patent issues related to biosimilar industries.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
THE ERISA INDUSTRY COMMITTEE (ERIC) via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to employer sponsored health plans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via FEROX STRATEGIES
2026 · third_quarter · Q3
Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURALEAF INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
General tax issues surrounding cannabis.
General cannabis rescheduling issues
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Treasury, Dept of
AVIDITY BIOSCIENCES, INC. via FEROX STRATEGIES
2026 · third_quarter · 3T
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATRIUM THERAPEUTICS via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
General issues related to trade.
General issues related to the automotive manufacturing industry.
General issues related to the defense industry.
ALLIANCE FOR AUTOMOTIVE INNOVATION via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to the automotive manufacturing industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to the rare disease pharmaceutical ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via FEROX STRATEGIES
2026 · third_quarter · Q3
General issues related to generic development and commercialization.
General issues related to trade.
General issues related to treatment access.
GOGO BUSINESS AVIATION LLC via FEROX STRATEGIES
2026 · third_quarter · RR
General issues related to aviation and telecommunications.
General issues related to aviation and telecommunications.
NEURELIS, INC. via FEROX STRATEGIES
2026 · third_quarter · RR
General issues related to federal regulation of the healthcare industry.
General issues related to federal regulation of the healthcare industry.
THE ERISA INDUSTRY COMMITTEE (ERIC) via FEROX STRATEGIES
2026 · third_quarter · RR
General issues related to employee sponsored health insurance.
General issues related to employee sponsored health insurance.
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
Issues related to renewable natural gas.
Issues related to general tax issues.
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
Discussions regarding Medicare coverage for pharmacy services.
General issues related to organized retail crime and pricing.
General issues related to trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via FEROX STRATEGIES
2026 · second_quarter · Q2
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2026 · second_quarter · Q2
General issues related to skin substitutes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STOKE THERAPEUTICS via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to rare disease treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to tariffs.
General issues related to rare disease treatment.
General issues related to rare disease treatment development.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the tobacco industry.
Issues related to illicit trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NCTA-THE INTERNET & TELEVISION ASSOCIATION via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to telecommunications, spectrum, and rural broadband. General issues related to privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RETAIL FEDERATION via FEROX STRATEGIES
2026 · second_quarter · Q2
General Issues related to technology and artificial intelligence.
General issues related to retail.
General issues related to organized retail crime.
NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to radiopharmaceutical tariffs.
General issues related to radiopharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL GRAB TECHNOLOGIES via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the deployment of technology at ports of entry.
General issues related to Homeland Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to trade.
General healthcare issues related to biosimilar industries.
General patent issues related to biosimilar industries.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via FEROX STRATEGIES
2026 · second_quarter · Q2
Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DECISION SCIENCES INTERNATIONAL CORP via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the deployment of technology at ports of entry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURALEAF INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
General tax issues surrounding cannabis.
General cannabis rescheduling issues
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Treasury, Dept of
AVIDITY BIOSCIENCES, INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATRIUM THERAPEUTICS via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
General issues related to trade.
General issues related to tax.
General issues related to the defense industry.
General issues related to the automotive manufacturing industry.
ALLIANCE FOR AUTOMOTIVE INNOVATION via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the automotive manufacturing industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to the rare disease pharmaceutical ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via FEROX STRATEGIES
2026 · second_quarter · Q2
General issues related to generic development and commercialization.
General issues related to treatment access.
General issues related to patents and access to generics/biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
General issues related to the defense industry.
General issues related to tax.
General issues related to the automotive manufacturing industry.
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to renewable natural gas.
Issues related to general tax issues.
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Discussions regarding Medicare coverage for pharmacy services.
General issues related to trade.
General issues related to organized retail crime and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via FEROX STRATEGIES
2026 · first_quarter · Q1
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
TELEVISAUNIVISION, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to telecommunications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
General issues related to skin substitutes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STOKE THERAPEUTICS via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to rare disease treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to tariffs.
General issues related to rare disease treatment.
General issues related to rare disease treatment development.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to the tobacco industry.
Issues related to illicit trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NCTA-THE INTERNET & TELEVISION ASSOCIATION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to telecommunications, spectrum, and rural broadband. General issues related to privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RETAIL FEDERATION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to data privacy.
General issues related to organized retail crime.
General Issues related to technology and artificial intelligence.
NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to radiopharmaceutical tariffs.
General issues related to radiopharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL GRAB TECHNOLOGIES via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to the deployment of technology at ports of entry.
General issues related to Homeland Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via FEROX STRATEGIES
2026 · first_quarter · Q1
General healthcare issues related to biosimilar industries.
General patent issues related to biosimilar industries.
General issues related to trade.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DECISION SCIENCES INTERNATIONAL CORP via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to the deployment of technology at ports of entry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURALEAF INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
General cannabis rescheduling issues
General tax issues surrounding cannabis.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
AVIDITY BIOSCIENCES, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATRIUM THERAPEUTICS via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AUTOMOTIVE INNOVATION via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to the automotive manufacturing industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FEROX STRATEGIES
2026 · first_quarter · Q1
Issues related to rare disease pharmaceuticals, ORPHAN Cures, and Pediatric Priority Review Voucher
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via FEROX STRATEGIES
2026 · first_quarter · Q1
General issues related to generic development and commercialization.
General issues related to treatment access.
General issues related to patents and access to generics/biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · RR
General issues related to the automotive and defense industries.
General issues related to the automotive and defense industries.
AGE IN PLACE via FEROX STRATEGIES
2026 · first_quarter · RR
General issues related to digital health.
ASSOCIATION FOR ACCESSIBLE MEDICINES via FEROX STRATEGIES
2026 · first_quarter · RR
General issues related to generic and biosimilar drug development.
General issues related to generic and biosimilar drug development.
General issues related to generic and biosimilar drug development.
ATRIUM THERAPEUTICS via FEROX STRATEGIES
2026 · first_quarter · RR
General issues related to rare disease pharmaceuticals.
General issues related to rare disease pharmaceuticals.
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2025 · fourth_quarter · Q4
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Issues related to general tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to trade.
General issues related to organized retail crime.
Discussions regarding Medicare coverage for pharmacy services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via FEROX STRATEGIES
2025 · fourth_quarter · Q4
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations and National Defense Authorization Act (S. 1071).
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
TELEVISAUNIVISION, INC. via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to telecommunications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
General issues related to skin substitutes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STOKE THERAPEUTICS via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to rare disease treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOUTH COAST AIR QUALITY MANAGEMENT DISTRICT via FEROX STRATEGIES
2025 · fourth_quarter · 4T
General issues related to clean air policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to rare disease treatment development.
General issues related to rare disease treatment.
General issues related to tariffs.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY (FORMERLY KNOWN AS REYNOLDS AMERICAN) via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to the tobacco industry.
Issues related to illicit trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NCTA-THE INTERNET & TELEVISION ASSOCIATION via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to telecommunications, spectrum, and rural broadband. General issues related to privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL RETAIL FEDERATION via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to retail.
General issues related to tax.
General issues related to organized retail crime.
NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA) via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to radiopharmaceuticals.
General issues related to radiopharmaceutical tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL GRAB TECHNOLOGIES via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to the deployment of technology at ports of entry.
General issues related to Homeland Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to trade.
General healthcare issues related to biosimilar industries.
General patent issues related to biosimilar industries.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via FEROX STRATEGIES
2025 · fourth_quarter · Q4
Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DECISION SCIENCES INTERNATIONAL CORP via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to the deployment of technology at ports of entry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CURALEAF INC. via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General cannabis rescheduling issues
General tax issues surrounding cannabis
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
AVIDITY BIOSCIENCES, INC. via FEROX STRATEGIES
2025 · fourth_quarter · Q4
Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR AUTOMOTIVE INNOVATION via FEROX STRATEGIES
2025 · fourth_quarter · Q4
General issues related to the automotive manufacturing industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FEROX STRATEGIES
2025 · fourth_quarter · Q4
Issues related to rare disease pharmaceuticals, Orphan Cures H.R. 946, and Pediatric Priority Review Voucher.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASTE MANAGEMENT, INC. via FEROX STRATEGIES
2025 · third_quarter · Q3
Issues related to solid waste, recycling, waste to energy, and environmental policy.
Issues related to general tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
WALMART INC. via FEROX STRATEGIES
2025 · third_quarter · Q3
General issues related to trade.
General issues related to swipe fee reforms.
General issues related to organized retail crime.
TELEVISAUNIVISION, INC. via FEROX STRATEGIES
2025 · third_quarter · Q3
General issues related to telecommunications.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STOKE THERAPEUTICS via FEROX STRATEGIES
2025 · third_quarter · Q3
General issues related to rare disease treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOUTH COAST AIR QUALITY MANAGEMENT DISTRICT via FEROX STRATEGIES
2025 · third_quarter · Q3
General issues related to clean air policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via FEROX STRATEGIES
2025 · third_quarter · Q3
General issues related to rare disease treatment development.
General issues related to rare disease treatment.
General issues related to tariffs.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NCTA-THE INTERNET & TELEVISION ASSOCIATION via FEROX STRATEGIES
2025 · third_quarter · Q3
General issues related to telecommunications, spectrum, and rural broadband. General issues related to privacy legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General issues related to retail.
General issues related to tax.
General issues related to data privacy.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
General issues related to tax.
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
General issues related to patents and access to generics/biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
General issues related to data privacy.
General issues related to trade.
General issues related to tax.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
General issues related to trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
General issues related to tax.
General issues related to retail.
General issues related to trade.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
General issues related to data privacy.
General Issues related to technology and artificial intelligence.
General issues related to trade.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Discussions regarding Medicare coverage for pharmacy services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE